Amicus Therapeutics Inc 2021 Sustainability Report
Company: Amicus Therapeutics Inc
Sector: Manufacturing
Country: United States
Year: 2021
Type: Sustainability Report
Pages: 22
The report presents Amicus's inaugural ESG program for its rare-disease biotechnology business, emphasizing environmental, social, and governance responsibilities. It highlights environmentally responsible facilities, including energy and water conservation measures and approximately 75% construction and demolition waste diversion. The report also details 2020 philanthropy, including $1,750,386 in U.S. contributions allocated to charitable causes.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.